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Abstract
Objectives: Neurophysiologic studies of mindfulness link the health benefits of meditation to activation of the
left-anterior cerebral cortex. The similarity and functional importance of intention and attentional stance in
meditative and biofield therapeutic practices suggest that modulation of recipient anterior asymmetric activation
may mediate the energetic effects of intention-based biofield treatments as well. The aim of the current study
was to test this hypothesis by using a treatment modality known as IRECA (Istituto di Ricerca sull’Energia
Cosmica Applicata).
Design: Participants’ electroencephalograms (EEG) were recorded over a 5-minute recovery period (subdivided
into three 100-second intervals) while participants received genuine IRECA, placebo treatment, or no treatment,
after completion of a cognitively demanding task.
Participants: 21 undergraduate students (3 men and 18 women; mean age, 22.1 years). All were right-handed
and none had a history of neurologic or psychological impairment.
Outcome measures: (1) Alpha Asymmetry Index (AAI), a standard measure of anterior asymmetric activation
of the cerebral cortex, defined as the average right hemisphere minus left hemisphere log alpha power of EEG
recordings for homologous pairs of electrodes in frontal and prefrontal regions; (2) self-report measures of state
anxiety obtained at baseline, before treatment, and after treatment, using a short form of the State-Trait Anxiety
Inventory.
Results: In line with predictions, recipients of IRECA showed enhanced left-anterior activation of the cerebral
cortex relative to placebo and no-treatment controls (as indicated by significantly higher and significantly
positive AAI scores) during the first 100 seconds of treatment, and they reported greater overall reduction in
state anxiety relative to baseline measures.
Conclusions: The current study provides preliminary supporting evidence for an intention-based biofield
therapeutic modality offsetting the negative effects of stress via sympathetic activation of recipients’ left-
anterior cerebral cortex.
Introduction
S
tudies of the neurophysiologic effects of intention-
based biofield therapeutic modalities such as Reiki, Johrei,
Therapeutic Touch, or qigong are rare. Although a variety of
changes in cortical electroencephalography (EEG) activity
have been reported coincident with treatment,1–6 research in
this area (while suggestive of treatment effects) frequently
suffers frommethodologic weaknesses, including omission of
adequate controls and statistical analyses and/or lack of an
appropriate theoretical rationale for choice of analytic focus
and interpretation. By contrast, neurophysiologic studies
of mindfulness meditation have, over many years, shown a
connection between the positive effects of meditative practice
and activation of the left-anterior cerebral cortex in line with
predictions grounded in the neuropsychology of emotion.7
Given the marked similarity and overlap of meditative and
biofield therapeutic practices—in particular, their common
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emphasis on the facilitative function of practitioner intention,
attention, and detached noninterference8,9—it seems reason-
able to hypothesize that modulation of recipient anterior
asymmetric activation may likewise play a role in biofield
therapeutic modalities as well. The purpose of the current study
was to investigate this possibility.
The association between positive/negative affect and
differential activation of the left-anterior/right-anterior ce-
rebral cortex is well documented; this association underlies
the established clinical use of magnetic fields for energeti-
cally inducing differential anterior activation as a success-
ful treatment for depression.10,11 Left-anterior activation, as
evidenced by alpha desynchronization and a correspond-
ing decrease in EEG alpha power relative to the opposite
hemisphere, is also known to increase with mindfulness
meditation,12–16 and to be correlated with improved immune
function, increased vitality, approach-oriented motivation,
and general well-being; right-anterior activation, the re-
verse.9,17–19 Moreover, individuals with greater left-anterior
activation recover more quickly from exposure to negative
stimulation, suggesting left-anterior activation to be an ef-
fective adaptation to stress.13 While left-anterior activation
has also been reported in recipients of intention-based bio-
field applications,5 lack of adequate controls render it un-
clear as to whether this is an effect of treatment over and
above, or distinct from, that of a placebo (notwithstanding
that ‘‘placebo’’ is a problematic construct in this area).20
Nevertheless, left-anterior activation is consistent with other
reported patterns of psychophysiologic changes in recipients
of Reiki and Johrei, including decreases in heart rate and
blood pressure,21–23 improved immune system functioning,
anxiety reduction, enhanced mood, and increased vitality.24–27
Collectively then, these findings suggest that energetic stim-
ulation from intention-based biofield applications may simi-
larly offset negative affect and improve well-being via
modulation of anterior hemispheric alpha activity in the brain.
The application we focus on here is IRECA. IRECA is an
acronym for Istituto di Ricerca sull’Energia Cosmica Ap-
plicata (Institute for Research in Applied Cosmic Energy),
founded in Italy in the 1990s by Dr. Natale Finocchiaro
under the guidance of contemporary Master and Teacher
of ‘‘The Way,’’ Alfredo Offidani,28 with the intention of
revivifying and disseminating traditional means of ‘‘energy
work’’ in a form suitable for use in ordinary everyday life.
One such method, or group of techniques, of Middle Eastern
traditional origin developed and taught by members of the
Institute under the aegis of the registered nonprofit organi-
zation Life Quality Project International,29,30 has become
known simply as IRECA. The method is widely practiced
throughout Latin America, Mexico, and southern Europe,
and aside from everyday use provides an ideal instrument
for scientific investigation of the energetic effects of inten-
tion on human neurophysiology—treatment is simple, short
in duration ( < 5 minutes), and requires only comparatively
brief training to be used effectively.
Practicing IRECA involves learning to use intention and
attention (‘‘presence’’) with an attitude of noninterference to
facilitate energetic changes in the mind-body, typically for
therapeutic and/or performance enhancement purposes. To
this end, it uses the familiar operational framework of ‘‘en-
ergy centers’’ and ‘‘energy transmission’’ common to many
other traditional systems, the primary function of which is
instrumental, however, not explanatory (the question of
the sense in which these constructs ‘‘really exist’’ is consid-
ered unimportant for practical purposes). Aside from this,
practitioners claim the essential difference between IRECA
and other biofield practices, such as Reiki or Johrei, is a
qualitative one stemming from a difference of tradition, or
originating intention, which can be felt or perceived experi-
entially. Additionally, as noted, IRECA treatments are often
simpler and shorter in duration than other similar techniques.
To date, studies of IRECA exist only in the form of un-
published case histories conducted by individual practi-
tioners and collated by the Institute. Reasons for lack of
scientific publication appear to be part sociocultural, part
phenomenologic, in that IRECA as a practice or mode of
enquiry emphasizes person-to-person communication, and
understanding and verification through direct experience,
over and above theory or written argument. As such, it can
be difficult to translate its study into a scientific context,
where the general expectation is that any research be posi-
tioned with reference to the history, discursive practices, and
normative expectations of a given scientific research com-
munity, without compromising the integrity of either world-
view. The current paper is an attempt to address this issue.
This preliminary study assessed neurophysiologic chan-
ges in the anterior cortex with use of IRECA to assist re-
covery from stress induced by completion of a cognitively
demanding task. Using an experimental paradigm similar to
that used by Laidlaw and colleagues in a study of Johrei,26
the current study investigated differences in recipients’ EEG
results and self-reported anxiety while receiving genuine
treatment, placebo treatment, or no treatment. In line with
the neuropsychological literature on emotion and mindful-
ness meditation, it was predicted that the genuine treatment
group would display enhanced left-anterior activation and
report greater reduction in anxiety relative to placebo re-
cipients and no-treatment controls.
Materials and Methods
Participants
Participants were 21 healthy, right-handed undergraduate
students (mean age, 21.1 years; 3 men and 18 women), with
no experience with IRECA. All participants volunteered to
take part in the study via the university’s research partici-
pation scheme.
Treatment
All treatments were administered by a trained IRECA
practitioner with 4 years’ experience of using the technique
daily. Treatment followed a commonly used procedure in
which the practitioner stood behind the recipient with an
attitude of detached yet compassionate noninterference and
a conscious intention to assist recovery, while focusing at-
tention on one or more of the recipient’s ‘‘energy centers.’’
In IRECA, as in techniques such as Reiki, Johrei, or qigong,
this inner posture is held to facilitate a form of vital energy
transfer in accordance with the needs of the individual or
situation. The energy centers used in IRECA are similar to
those of the yogic chakra system; although these centers are
themselves nonmaterial, for operational purposes they are
conceived of as ‘‘located’’ at specific positions on the head
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and spine that are associated with the regulation and expres-
sion of various aspects of psychophysiological functioning.30
In the IRECA condition, the practitioner focused attention
on each of the following centers in succession: C7, C7+C6,
C7 +C5, and C4 (Fig. 1). In each case the practitioner po-
sitioned one or other of his hands approximately 10–15 cm
away from the relevant center while monitoring his finger-
tips for a change in sensation signalling completion of
treatment for that center (the so-called return of energy). In
the placebo condition, the practitioner enacted outward
movements identical to those in the IRECA condition, but
without intention to assist recovery and with attention in-
wardly distracted by a mental arithmetic task involving
successive doubling of numbers. In the no-treatment con-
dition, the participant was left alone in the room.
Participants were informed beforehand that they would be
randomly allocated to one of the experimental conditions but
would not be told which. Allocation to condition was made
on a session-by-session basis by the practitioner in a separate
room immediately before treatment via selection of a folded
paper tab from a box initially containing 21 such tabs, 7 each
of which were marked with 1 of the 3 experimental condi-
tions. Participants remained with their eyes closed throughout
the treatment phase, and there was no talk or physical contact
between practitioner and recipient at any time. All test ad-
ministration and EEG recording were conducted by a re-
search assistant who was blind to experimental condition.
Procedure
Participants were tested individually in a quiet room,
seated in a comfortable chair. Following EEG capping, they
first completed a short form of the State-Trait Anxiety In-
ventory (STAI) state scale consisting of six items each as-
sessed via a four-point Likert scale,31 after which they were
given an auditory N-back memory task to perform for 2–3
minutes to induce mild cognitive stress.32 They then com-
pleted the STAI a second time, after which they were asked
to close their eyes, place their hands palm-down on their
upper legs, and remain calm, still, and relaxed. The research
assistant then left the room and commenced EEG recording
while the practitioner entered and administered ‘‘treatment’’
for 5 minutes. Start and finish times were logged as markers
on the EEG trace using E-Prime 2.0 (Psychology Software
Tools, Inc., Sharpsburg, PA) via a foot switch located in the
treatment room.33 On completion, the practitioner left the
room and the research assistant re-entered to administer
the third and final STAI.
EEG recording and analysis
The EEG was recorded from a 64-channel WaveGuard
cap (ANT Neuro, Enschede, the Netherlands) using small
sintered Ag/AgCl electrodes placed according to the 10–20
standard system of the American Electroencephalographic
Society, with all wires shielded against outside electrical noise.
An average reference was used. The signals were digitized
online with a sampling frequency of 512Hz with a 0.01–100-
Hz band-pass filter. Electrode impedance was maintained be-
low 10kO (mostly under 5 kO). The software package ASA
was used to analyze the waveforms (http://www.ant-neuro
.com/). To track change over time, EEG data during the
treatment phase were divided into three 100-second segments
(T100, T200, and T300), each of which was parsed into twenty
5-second epochs and processed using Fourier fast transform
averaging to derive relative power density data in the alpha
frequency band (7.5–12.5Hz). EEG data were screened for eye
movements, electrode drifting, amplifier blocking, and electro-
myographic artifacts, with all segments containing such artifacts
excluded from further analysis; 85.2% of the epochs were
included. Three participants (one per condition) were omit-
ted from the final analysis because of technical problems
with recording and/or artifacts in the data. All data were log-
transformed before averaging to increase normality.
Asymmetric activation
Anterior asymmetric activation was measured by means
of the alpha asymmetry index (AAI), a commonly used
metric in emotion and mindfulness research, calculated as
the average right hemisphere minus the left hemisphere log
alpha power for homologous pairs of electrodes.13,14 Dif-
ferences were calculated for electrode pairs in frontal and
prefrontal regions (AF3-AF4, AF7-AF8, F1-F2, F3-F4, F5-
F6, and F7-F8), then averaged across sites to increase the
signal:noise ratio.34 The AAI reflects an inverse relationship
between EEG power and alpha desynchronization due to
out-of-phase wave cancellation resulting from activation of
independently oscillating neural units.35 A positive value
indicates left-sided activation; a negative value indicates
right-sided activation.
Results
Figure 2 shows changes in anterior asymmetric activation
during the treatment phase. Two-way analysis of variance
FIG. 1. Energy centers used in IRECA (Istituto di Ricerca
sull’Energia Cosmica Applicata).
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on AAI scores by time and condition found a main effect of
time (F[2,30]= 5.563, p= 0.009, gp
2
= 0.271) and a significant
time by condition interaction (F[4,30]= 2.755, p= 0.046,
gp
2
= 0.269). Post hoc comparisons with Bonferroni correc-
tions found anterior alpha asymmetry during the early phase
of treatment (T100) to be significantly more positive in the
IRECA condition than in both placebo ( p= 0.037, d= 2.112)
and no-treatment ( p= 0.002, d= 2.077) controls. There were
no significant differences between groups during the mid
(T200) or final (T300) phases. Additional one-sample t tests
with 0 as the criterion reference (where 0= no asymmetry)
showed the degree of asymmetry in the IRECA group
during T100 to indicate significant left-sided activation
(t[5]= 3.078, p= 0.028, d= 1.778) and that of placebo controls
during T300 to indicate significant right-sided activation
(t[5]= - 2.770, p= 0.039, d = - 1.599).
Analysis of within-group changes in AAI scores across the
treatment phase found a significant linear trend in the IRECA
group (F[1,5]= 16.523, p= 0.010, gp
2
= 0.768) and a signifi-
cant quadratic trend in the placebo group (F[1,5]= 18.883,
p= 0.007, gp
2
= 0.791). While all three groups showed similar
levels of right-sided activation at T300 (although, as noted,
only in the placebo group was the degree of activation sta-
tistically significant), the IRECA group showed a gradual
shift from left-sided to right-sided activation across the
treatment phase, whereas the placebo group displayed a shift
in the opposite direction from T100 to T200 before reverting
to initial levels of right-sided activation at T300 (Fig. 2). The
no-treatment group displayed a pattern similar to that of the
placebo group, but the trend was not statistically significant.
Accordingly, post hoc comparisons of within-group means,
again with Bonferroni corrections, showed AAI scores to be
significantly more positive at T100 than T300 in the IRECA
group ( p= 0.029; d= 2.002) and significantly more positive at
T200 than T300 in the placebo group ( p= 0.022; d= 1.856).
Table 1 shows self-reported anxiety levels before and after
treatment. Two-way analysis of variance on STAI scores by
time and condition found a main effect of time (F[2,34]=
12.778, p<0.001, gp
2
=0.429) and a marginal interaction
between time and condition (F[4,34]=2.560, p=0.056,
gp
2
=0.231). Post hoc comparisons with Bonferroni corrections
found significant reductions in self-reported anxiety in the
IRECA group from baseline to post-treatment (p=0.012,
d=1.787) and from pretreatment to post-treatment (p=0.031,
d=1.667). By contrast, no reduction in self-reported anxiety
occurred over time in the no-treatment group, or from baseline
to post-treatment in the placebo group. Significant reduction
in self-reported anxiety did occur in the placebo group from
pretreatment to post-treatment (p=0.022, d=1.826), but this
was only to baseline level. Although self-reported anxiety
did not significantly differ between groups at baseline or pre-
treatment, self-reported anxiety levels in the IRECA group
were significantly lower than in the placebo group after treat-
ment ( p=0.022, d= 1.686).
Discussion
In summary, in line with predictions derived from the
neuropsychological literature on emotion and mindfulness,
recipients of IRECA showed significantly greater left-anterior
activation of the cerebral cortex during the initial phase of
treatment compared with placebo and no-treatment controls;
moreover, the degree of left-anterior activation was itself
statistically significant. Asymmetric activation per se tended to
diminish in all three groups during the midphase of treatment
and to increase again in the right anterior hemisphere during
the final phase. Recipients of IRECA reported greater overall
reduction in anxiety relative to baseline measures than did
placebo and no-treatment controls.
It is significant that left-anterior activation during the first
100 seconds of treatment not only coincided with the period
immediately following stress induction, but with the practi-
tioner’s treatment of centers C7 and C6, located on the top of
the head and forehead, respectively (Fig. 1), both of which
are associated with cerebral functioning. This suggests the
possibility of some form of local energetic stimulation of the
frontal cortex analogous to that produced by magnetic fields
in treatments for depression.10 However, whereas magnetic
fields are applied to one or other side of the head (depending
on whether activation is being induced or inhibited), in IR-
ECA the practitioner’s hands are positioned—and attention
is focused—on central positions lying on the midline be-
tween the two hemispheres. It is thus unclear why local
stimulation of the cerebral cortex via the practitioner’s hands
should affect one hemisphere differently than the other.
Arguably, the effect is more likely to be nonlocal, or inten-
tional, as practitioners themselves maintain.
The tendency for right-anterior activation to diminish in
control groups during the midphase of treatment is likely
due to natural decay of the effects of the stressor task (which
FIG. 2. Changes in anterior asymmetric activation across
time and condition.
Table 1. Mean State-Trait Anxiety Inventory
Scores Across Time and Condition
Study group Baseline Pretreatment Post-treatment
IRECA 9.14 (1.95)* 9.71 (2.29) 6.57 (0.98)
Placebo
treatment
9.17 (1.83) 11.67 (1.03) 9.00 (1.79)
No treatment 9.00 (1.29) 8.71 (2.56) 7.71 (1.50)
*Numbers in parentheses are standard deviations.
IRECA, Istituto di Ricerca sull’Energia Cosmica Applicata.
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were mild). If so, however, this raises the question of why a
reverse tendency should be seen in all three groups during
the final phase, and why in the case of the IRECA group in
particular did continuing treatment not offset this tendency
as it did during the initial phase? The latter also suggests
that lower post-treatment self-reported anxiety in the IRECA
group may in effect constitute a retrospective evaluation of
treatment per se rather than a measure of current affective
state. One possibility is that the tendency toward right-sided
activation during the final phase reflects emotional fatigue
caused by ongoing exposure to laboratory conditions, and
that the lack of treatment effect indicates a mismatch be-
tween the nature of the problem and the specific ‘‘energy
centers’’ treated. Unlike the initial phase where, as noted,
treatment of C7 and C6 was functionally concordant with
the nature of the stress involved, itself primarily cogni-
tive, in the final phase treatment may not have been op-
timal if emotional fatigue were the underlying issue. From
the operational perspective of IRECA, treatment of C3
and C2 would be thought more appropriate in this context,
but this was not included in the experimental protocol. If
correct, this interpretation underscores a basic principle of
IRECA and other traditional systems that energy centers
are functionally (and/or intentionally) related to distinct
aspects of psychophysiologic behavior, while suggesting
that anterior asymmetric activation may provide a useful
generic indicator of treatment action and efficacy. Future
research could address this possibility through exploring
the comparative effects on anterior asymmetric activation
of treating each specific center under a range of different
stressor conditions.
If a functional relationship does exist between specific
energy centers, psychophysiologic processes and treatment
efficacy, this raises the question of the ontologic nature of
that relationship. As noted, while for practical purposes the
energy centers used in IRECA are conceived of as anatomic
locations, they are not in themselves understood as occu-
pying space in the normal physical sense; rather, they are
‘‘imaginal’’ objects (as distinct from ‘‘imaginary’’),36 not
material. As such, their mode of influence is nonlocal and
noncausal, operating in the experiential dimension of in-
tention and presence, and not via physical energy trans-
mission through or across space as is often described and/or
assumed.3,37 While the latter provides a convenient working
metaphor in therapeutic contexts (including IRECA), if
taken literally it is misleading for scientific purposes.38
Interestingly, recent attempts by neurophysiologists at
theorizing the link between mindfulness (or presence) and
anterior asymmetric activation have also foregrounded the
role of intention in neurophysiologic activity. Schwartz and
colleagues have argued from a quantum-theoretical per-
spective that intention on a specific goal initiates a process
of neural self-organization in which conscious attention
facilitates collapse of the global quantum superpositional
brain state in such a way that resultant patterns of neural
activity tend to actualize the intended outcome.39 According
to Schwartz and colleagues, intention controls attention
density, which itself increases the probability of one brain
state occurring rather than another, thus overriding and re-
organizing habitual patterns of neural response. Similarly,
Freeman, in discussing the salience of Aquinas’ concept of
intention as ‘‘action into the world’’ for understanding
nonlinear brain dynamics, emphasizes the influence of in-
tention on the ongoing production, selection, and actual-
ization of potential patterns of sensorimotor neural activity
in accordance with changes in an organism’s environment
or context.40 Both approaches argue for the unity of mind,
brain and body, and accord intention a primary, non-
reducible, nonlocal potentiating role in neurophysiologic
activity.
While such models lend themselves well to accounting
for neurophysiologic effects of intention at an individ-
ual level, if intention acts nonlocally, as Schwartz and col-
leagues suggest, there is no reason in principle why these
effects should occur only within biologically defined indi-
viduals. Arguably, the theory also allows for the way one
person directs intention to affect, or potentiate, the mind-
brain-body state of another, as is claimed by practitioners
of intention-based treatment modalities and for which the
present study offers preliminary supporting evidence. More-
over, such effects, if they exist, should in theory be inde-
pendent of physical proximity. Equally, it is important to
acknowledge that the meaning of the term intention origi-
nally also encompassed the inherent tendency of the body
toward health as its natural or optimal energetic state of
well-being—a state we know in part to be associated with
left-anterior activation of the cerebral cortex—and that, as
Weiner and Greene have recently argued, intention-based
treatment modalities may facilitate, or energetically assist,
the operation of this unconscious tendency in the recipient
through its sympathetic alignment, or entanglement, with
the conscious intention of the practitioner.41 As such, this
may in part account for why, as in mindfulness meditation,
an attitude of detached noninterference or nonego involve-
ment on the part of the practitioner is held to be an important
determinant of treatment efficacy.
Because the present study was preliminary in nature,
it necessarily focused on immediate proximal effects of
treatment rather than its potential long-term benefits. How-
ever, studies of experienced meditators have found evidence
for permanent changes in anterior activation associated with
regular mindfulness practice over prolonged periods of time;
an example of the more general phenomenon known as self-
directed neuroplasticity.39 As IRECA and other intention-
based biofield modalities are typically used not only for
remedial purposes but on a daily basis for general mainte-
nance of health and well-being, it seems reasonable to as-
sume that similar long-term changes in brain activity may
also occur with regular use of these practices as well. Future
longitudinal studies could address this possibility.
While the present study was methodologically sound in
terms of blinding procedures, randomisation and controls,
future studies may benefit from the following modifications.
Firstly, in order to better maximise sensitivity to treatment-
related changes in EEG, and in accordance with known
individual differences in dominant EEG frequencies, data
collection and analyses might more usefully employ indi-
vidually-defined alpha frequency ranges rather than a con-
ventionally-defined bandwidth.35,42 Secondly, while clear and
predicted differences in neurophysiologic response were still
observed in the genuine treatment group relative to placebo
and no-treatment controls immediately after task, and simi-
larly in post-treatment self-report measures of anxiety relative
to baseline, the fact that the N-back task used in the present
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study for elevating levels of pretreatment anxiety produced
only minor and/or inconsistent effects suggests future studies
using this task as a stressor should make the value of N
contingent on prior performance to maximize its effect on a
given individual. Future studies might also include additional
physiologic measures of stress response, such as skin con-
ductance or heart rate variability, allowing analysis of co-
variation of such measures with asymmetric activation and
thereby circumventing the issue of confounding self-report
measures of affective state with retrospective treatment
evaluation as noted above. Finally, the issue of local versus
nonlocal action could be usefully addressed via addition of a
proximal-remote treatment condition, while also recording
EEG from practitioner and recipient simultaneously.43
Conclusions
The current study provides preliminary supporting evi-
dence for an intention-based biofield therapeutic modality
offsetting the negative effects of stress via sympathetic ac-
tivation of recipients’ left-anterior cerebral cortex.
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